Advertisement

Breast Cancer-Related Lymphedema

  • Heli KavolaEmail author
  • Sinikka Suominen
Chapter
  • 1.7k Downloads

Abstract

Lymphedema is a common long-term complication of breast cancer treatment with a significant impact on quality of life and possibly life-threatening consequences. Major risks factors are axillary lymph node dissection, radiation and obesity. Early detection and treatment may limit progressive arm volume increase. Conservative treatment consists of weight reduction/control, exercise, skin care and compression garments. Some patients may benefit from decongestive lymphatic therapy if the symptoms are not controlled by compression garment alone. Surgical management, such as liposuction, lymphatico-venous anastomoses and vascularized lymph node transfer, can be considered in selected patients, although objective long-term results are limited.

Keywords

Lymphedema Obesity Axillary lymph node dissection Radiation Compression garment Decongestive lymphatic therapy Lymphatico-venous anastomosis Vascularized lymph node transfer Liposuction 

References

  1. 1.
    DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Kwan ML, Darbinian J, Schmitz KH, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg. 2010;145:1055–63.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–9.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Paskett ED, Naughton MJ, McCoy TP, et al. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomark Prev. 2007;16:775–82.CrossRefGoogle Scholar
  6. 6.
    Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.PubMedCrossRefGoogle Scholar
  7. 7.
    Goldberg JI, Wiechmann LI, Riedel ER, et al. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17:3278–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65:55–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491–500.PubMedCrossRefGoogle Scholar
  10. 10.
    Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17:1371–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Maclellan R. The lymphatic system. In: Greene A, Slavin S, Brorson H, editors. Lymphedema: presentation, diagnosis and treatment. Switzerland: Springer International Publishing; 2015. p. 3–7.Google Scholar
  12. 12.
    Zampell JC, Aschen S, Weitman ES, et al. Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg. 2012;129:825–34.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798–802.PubMedCrossRefGoogle Scholar
  14. 14.
    Hespe G, Nitti M, Mehrara B. Pathophysiology of lymphedema. In: Greene A, Slavin S, Brorson H, editors. Lymphedema: presentation, diagnosis and treatment. Switzerland: Springer International Publishing; 2015. p. 9–18.Google Scholar
  15. 15.
    Aschen S, Zampell JC, Elhadad S, et al. Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg. 2012;129:838–47.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Brorson H, Ohlin K, Olsson G, et al. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol. 2006;4:199–210.PubMedCrossRefGoogle Scholar
  17. 17.
    Szuba A, Razavi M, Rockson SG. Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol. 2002;13:799–803.PubMedCrossRefGoogle Scholar
  18. 18.
    Coriddi M, Khansa I, Stephens J, et al. Analysis of factors contributing to severity of breast cancer-related lymphedema. Ann Plast Surg. 2015;74:22–5.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons oncology group trial Z0011. J Clin Oncol. 2007;25:3657–63.PubMedCrossRefGoogle Scholar
  20. 20.
    Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608–14.PubMedCrossRefGoogle Scholar
  22. 22.
    Kilbreath SL, Refshauge KM, Beith JM, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.PubMedCrossRefGoogle Scholar
  23. 23.
    Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26:3536–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Herd-Smith A, Russo A, Muraca MG, et al. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92:1783–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Helyer LK, Varnic M, Le LW, et al. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J. 2010;16:48–54.PubMedCrossRefGoogle Scholar
  26. 26.
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–52.PubMedCrossRefGoogle Scholar
  27. 27.
    Amore M, Tapia L, Mercado D, et al. Lymphedema: a general outline of its anatomical base. J Reconstr Microsurg. 2016;32:2–9.PubMedGoogle Scholar
  28. 28.
    Boccardo FM, Casabona F, Friedman D, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol. 2011;18:2500–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Leduc A, Caplan I, Leduc O. Lymphatic drainage of the upper limb. Eur J Lymphology Relat Probl. 1993;4:11–8.Google Scholar
  30. 30.
    Nesvold IL, Dahl AA, Lokkevik E, et al. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42.PubMedCrossRefGoogle Scholar
  31. 31.
    Shah C, Wilkinson JB, Baschnagel A, et al. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2012;83:1095–100.PubMedCrossRefGoogle Scholar
  32. 32.
    Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2003;55:1209–15.PubMedCrossRefGoogle Scholar
  33. 33.
    Hayes SB, Freedman GM, Li T, et al. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys. 2008;72:1449–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Avraham T, Yan A, Zampell JC, et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol. 2010;299:C589–605.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Weitman ES, Aschen SZ, Farias-Eisner G, et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One. 2013;8:e70703.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Savetsky IL, Torrisi JS, Cuzzone DA, et al. Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am J Physiol Heart Circ Physiol. 2014;307:H165–72.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg. 2014;134:154e–60e.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Miaskowski C, Dodd M, Paul SM, et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One. 2013;8:e60164.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Newman B, Lose F, Kedda MA, et al. Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol. 2012;10:2–13.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Finegold DN, Baty CJ, Knickelbein KZ, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 2012;18:2382–90.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol. 2007;46:1138–42.PubMedCrossRefGoogle Scholar
  42. 42.
    Kim M, Shin KH, Jung SY, et al. Identification of prognostic risk factors for transient and persistent lymphedema after multimodal treatment for breast cancer. Cancer Res Treat. 2016;48(4):1330–7.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Kilbreath SL, Lee MJ, Refshauge KM, et al. Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer. 2013;21:2207–15.PubMedCrossRefGoogle Scholar
  44. 44.
    Taghian NR, Miller CL, Jammallo LS, et al. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol. 2014;92:227–34.PubMedCrossRefGoogle Scholar
  45. 45.
    Ahmed RL, Prizment A, Lazovich D, et al. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s health study. J Clin Oncol. 2008;26:5689–96.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Alcorso J, Sherman KA. Factors associated with psychological distress in women with breast cancer-related lymphoedema. Psychooncology. 2016;25:865–72.PubMedCrossRefGoogle Scholar
  47. 47.
    International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the International Society of Lymphology. Lymphology. 2013;46:1–11.Google Scholar
  48. 48.
    Godal R, Swedborg I. A correction for the natural asymmetry of the arms in the determination of the volume of oedema. Scand J Rehabil Med. 1982;14:193–5.PubMedGoogle Scholar
  49. 49.
    Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3:208–17.PubMedCrossRefGoogle Scholar
  50. 50.
    Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959–72.PubMedCrossRefGoogle Scholar
  51. 51.
    Adriaenssens N, Buyl R, Lievens P, et al. Comparative study between mobile infrared optoelectronic volumetry with a Perometer and two commonly used methods for the evaluation of arm volume in patients with breast cancer related lymphedema of the arm. Lymphology. 2013;46:132–43.PubMedGoogle Scholar
  52. 52.
    Deltombe T, Jamart J, Recloux S, et al. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology. 2007;40:26–34.PubMedGoogle Scholar
  53. 53.
    Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34:2–11.PubMedGoogle Scholar
  54. 54.
    Warren AG, Janz BA, Slavin SA, et al. The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg. 2007;58:541–3.PubMedCrossRefGoogle Scholar
  55. 55.
    Mayrovitz HN, Weingrad DN, Davey S. Local tissue water in at-risk and contralateral forearms of women with and without breast cancer treatment-related lymphedema. Lymphat Res Biol. 2009;7:153–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Lahtinen T, Seppala J, Viren T, et al. Experimental and analytical comparisons of tissue dielectric constant (TDC) and bioimpedance spectroscopy (BIS) in assessment of early arm lymphedema in breast cancer patients after axillary surgery and radiotherapy. Lymphat Res Biol. 2015;13:176–85.PubMedCrossRefGoogle Scholar
  57. 57.
    Warren AG, Brorson H, Borud LJ, et al. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59:464–72.PubMedCrossRefGoogle Scholar
  58. 58.
    Sharma R, Wendt JA, Rasmussen JC, et al. New horizons for imaging lymphatic function. Ann N Y Acad Sci. 2008;1131:13–36.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Kleinhans E, Baumeister RG, Hahn D, et al. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med. 1985;10:349–52.PubMedCrossRefGoogle Scholar
  60. 60.
    Liu N, Zhang Y. Magnetic resonance lymphangiography for the study of lymphatic system in lymphedema. J Reconstr Microsurg. 2016;32:66–71.PubMedGoogle Scholar
  61. 61.
    Borri M, Schmidt MA, Gordon KD, et al. Quantitative contrast-enhanced magnetic resonance lymphangiography of the upper limbs in breast cancer related lymphedema: an exploratory study. Lymphat Res Biol. 2015;13:100–6.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    White RD, Weir-McCall JR, Budak MJ, et al. Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol. 2014;69:e435–44.PubMedCrossRefGoogle Scholar
  63. 63.
    Mihara M, Hara H, Araki J, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One. 2012;7:e38182.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Yamamoto T, Narushima M, Yoshimatsu H, et al. Dynamic indocyanine green (ICG) lymphography for breast cancer-related arm lymphedema. Ann Plast Surg. 2014;73:706–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Yamamoto T, Matsuda N, Doi K, et al. The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg. 2011;128:314e–21e.PubMedCrossRefGoogle Scholar
  66. 66.
    Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809–19.PubMedCrossRefGoogle Scholar
  67. 67.
    Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer. 2007;109:1949–56.PubMedCrossRefGoogle Scholar
  68. 68.
    Singh B, Disipio T, Peake J, et al. Systematic review and meta-analysis of the effects of exercise for those with cancer-related lymphedema. Arch Phys Med Rehabil. 2016;97:302–315.e13.PubMedCrossRefGoogle Scholar
  69. 69.
    Ahmed RL, Thomas W, Yee D, et al. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24:2765–72.PubMedCrossRefGoogle Scholar
  70. 70.
    McNeely ML, Peddle CJ, Yurick JL, et al. Conservative and dietary interventions for cancer-related lymphedema: a systematic review and meta-analysis. Cancer. 2011;117:1136–48.PubMedCrossRefGoogle Scholar
  71. 71.
    Kwan ML, Cohn JC, Armer JM, et al. Exercise in patients with lymphedema: a systematic review of the contemporary literature. J Cancer Surviv. 2011;5:320–36.PubMedCrossRefGoogle Scholar
  72. 72.
    Dayes IS, Whelan TJ, Julian JA, et al. Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer. J Clin Oncol. 2013;31:3758–63.PubMedCrossRefGoogle Scholar
  73. 73.
    Lasinski BB, McKillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012;4:580–601.PubMedCrossRefGoogle Scholar
  74. 74.
    Ezzo J, Manheimer E, McNeely ML, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015;5:CD003475. doi: 10.1002/14651858.CD003475.Google Scholar
  75. 75.
    Huang TW, Tseng SH, Lin CC, et al. Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol. 2013;11:15. doi: 10.1186/1477-7819-11-15.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Vignes S. Complex decongestive therapy. In: Greene A, Slavin S, Brorson H, editors. Lymphedema: presentation, diagnosis, and treatment. Switzerland: Springer International Publishing; 2015. p. 227–35.Google Scholar
  77. 77.
    Brorson H. Liposuction in lymphedema treatment. J Reconstr Microsurg. 2016;32:56–65.PubMedGoogle Scholar
  78. 78.
    Brorson H. Complete reduction of arm lymphedema following breast cancer – a prospective twenty-one years’ study. Plast Reconstr Surg. 2015;136:134–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Brorson H, Svensson H, Norrgren K, et al. Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology. 1998;31:156–72.PubMedGoogle Scholar
  80. 80.
    Frick A, Hoffmann JN, Baumeister RG, et al. Liposuction technique and lymphatic lesions in lower legs: anatomic study to reduce risks. Plast Reconstr Surg. 1999;103:1868–73. discussion 1874-5PubMedCrossRefGoogle Scholar
  81. 81.
    Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg. 2013;132:1305–14.PubMedCrossRefGoogle Scholar
  82. 82.
    Campisi C, Bellini C, Campisi C, et al. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30:256–60.PubMedGoogle Scholar
  83. 83.
    Basta MN, Gao LL, Wu LC. Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg. 2014;133:905–13.PubMedCrossRefGoogle Scholar
  84. 84.
    Mihara M, Hara H, Furniss D, et al. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema. Br J Surg. 2014;101:1391–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Baumeister RG, Mayo W, Notohamiprodjo M, et al. Microsurgical lymphatic vessel transplantation. J Reconstr Microsurg. 2016;32:34–41.PubMedGoogle Scholar
  86. 86.
    Becker C, Assouad J, Riquet M, et al. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243:313–5.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Becker C, Vasile JV, Levine JL, et al. Microlymphatic surgery for the treatment of iatrogenic lymphedema. Clin Plast Surg. 2012;39:385–98.PubMedCrossRefGoogle Scholar
  88. 88.
    Yan A, Avraham T, Zampell JC, et al. Mechanisms of lymphatic regeneration after tissue transfer. PLoS One. 2011;6:e17201.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Aschen SZ, Farias-Eisner G, Cuzzone DA, et al. Lymph node transplantation results in spontaneous lymphatic reconnection and restoration of lymphatic flow. Plast Reconstr Surg. 2014;133:301–10.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Cheng MH, Huang JJ, Wu CW, et al. The mechanism of vascularized lymph node transfer for lymphedema: natural lymphaticovenous drainage. Plast Reconstr Surg. 2014;133:192e–8e.PubMedCrossRefGoogle Scholar
  91. 91.
    Cheng MH, Chen SC, Henry SL, et al. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes. Plast Reconstr Surg. 2013;131:1286–98.PubMedCrossRefGoogle Scholar
  92. 92.
    Viitanen TP, Visuri MT, Hartiala P, et al. Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients. Plast Reconstr Surg Glob Open. 2013;1:1–9.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Becker C, Pham DN, Assouad J, et al. Postmastectomy neuropathic pain: results of microsurgical lymph nodes transplantation. Breast. 2008;17:472–6.PubMedCrossRefGoogle Scholar
  94. 94.
    Tourani SS, Taylor GI, Ashton MW. Vascularized lymph node transfer: a review of the current evidence. Plast Reconstr Surg. 2016;137:985–93.PubMedCrossRefGoogle Scholar
  95. 95.
    Barreiro GC, Baptista RR, Kasai KE, et al. Lymph fasciocutaneous lateral thoracic artery flap: anatomical study and clinical use. J Reconstr Microsurg. 2014;30:389–96.PubMedCrossRefGoogle Scholar
  96. 96.
    Althubaiti GA, Crosby MA, Chang DW. Vascularized supraclavicular lymph node transfer for lower extremity lymphedema treatment. Plast Reconstr Surg. 2013;131:133e–5e.PubMedCrossRefGoogle Scholar
  97. 97.
    Sapountzis S, Singhal D, Rashid A, et al. Lymph node flap based on the right transverse cervical artery as a donor site for lymph node transfer. Ann Plast Surg. 2014;73:398–401.PubMedCrossRefGoogle Scholar
  98. 98.
    Cheng MH, Huang JJ, Nguyen DH, et al. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol. 2012;126:93–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Viitanen TP, Maki MT, Seppanen MP, et al. Donor-site lymphatic function after microvascular lymph node transfer. Plast Reconstr Surg. 2012;130:1246–53.PubMedCrossRefGoogle Scholar
  100. 100.
    Vignes S, Blanchard M, Yannoutsos A, et al. Complications of autologous lymph-node transplantation for limb lymphoedema. Eur J Vasc Endovasc Surg. 2013;45:516–20.PubMedCrossRefGoogle Scholar
  101. 101.
    Dayan JH, Dayan E, Smith ML. Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer. Plast Reconstr Surg. 2015;135:277–85.PubMedCrossRefGoogle Scholar
  102. 102.
    Patel KM, Lin CY, Cheng MH. A prospective evaluation of lymphedema-specific quality-of-life outcomes following vascularized lymph node transfer. Ann Surg Oncol. 2015;22:2424–30.PubMedCrossRefGoogle Scholar
  103. 103.
    De Brucker B, Zeltzer A, Seidenstuecker K, et al. Breast cancer-related lymphedema: quality of life after lymph node transfer. Plast Reconstr Surg. 2016;137:1673–80.PubMedCrossRefGoogle Scholar
  104. 104.
    Saaristo AM, Niemi TS, Viitanen TP, et al. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg. 2012;255:468–73.PubMedCrossRefGoogle Scholar
  105. 105.
    Nguyen AT, Chang EI, Suami H, et al. An algorithmic approach to simultaneous vascularized lymph node transfer with microvascular breast reconstruction. Ann Surg Oncol. 2015;22:2919–24.PubMedCrossRefGoogle Scholar
  106. 106.
    Masia J, Pons G, Nardulli ML. Combined surgical treatment in breast cancer-related lymphedema. J Reconstr Microsurg. 2016;32:16–27.PubMedCrossRefGoogle Scholar
  107. 107.
    Suominen S, Kolehmainen M. Transverse myocutaneous gracilis with vascularized lymph node transfer. In: Neligan P, Masia M, Piller N, editors. Lymphedema: complete medical and surgical management. Boca Raton, Fl: CMC Press, Taylor and Francis; 2015. p. 519–25.Google Scholar
  108. 108.
    Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691–8.PubMedCrossRefGoogle Scholar
  110. 110.
    Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12:289–94.PubMedCrossRefGoogle Scholar
  111. 111.
    Masia J, Pons G, Rodriguez-Bauza E. Barcelona lymphedema algorithm for surgical treatment in breast cancer-related lymphedema. J Reconstr Microsurg. 2016;32:329–35.PubMedCrossRefGoogle Scholar
  112. 112.
    Lahteenvuo M, Honkonen K, Tervala T, et al. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation. 2011;123:613–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Plastic SurgeryHelsinki University HospitalHelsinkiFinland

Personalised recommendations